Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Etidronic-acid | hsa00010 | Glycolysis / Gluconeogenesis | 2.17E-02 | 3 | P04075, P04406, P60174 | ALDOA, GAPDH, TPI1 | More | | Etidronic-acid | hsa00020 | Citrate cycle (TCA cycle) | 3.65E-02 | 2 | O75390, P40926 | CS, MDH2 | More | | Etidronic-acid | hsa00051 | Fructose and mannose metabolism | 2.48E-02 | 2 | P60174, P04075 | TPI1, ALDOA | More | | Etidronic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Etidronic-acid | hsa00230 | Purine metabolism | 4.02E-02 | 2 | P31350, P21589 | RRM2, NT5E | More | | Etidronic-acid | hsa00240 | Pyrimidine metabolism | 2.54E-04 | 3 | P31350, P21589, P04818 | RRM2, NT5E, TYMS | More | | Etidronic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Etidronic-acid | hsa01200 | Carbon metabolism | 1.20E-02 | 4 | P04075, P04406, P60174, P40926 | ALDOA, GAPDH, TPI1, MDH2 | More | | Etidronic-acid | hsa01230 | Biosynthesis of amino acids | 1.28E-02 | 3 | P60174, P04406, P04075 | TPI1, GAPDH, ALDOA | More | | Etidronic-acid | hsa01523 | Antifolate resistance | 6.06E-03 | 2 | Q92820, P04818 | GGH, TYMS | More | | Etidronic-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Etidronic-acid | hsa03010 | Ribosome | 7.17E-06 | 15 | P62753, P32969, P30050, P40429, P62906, P62917, P46776, Q9H0U6, Q07020, P61513, P36578, P27635, P05386, P62249, P23396 | RPS6, RPL9, RPL12, RPL13A, RPL10A, RPL8, RPL27A, MRPL18, RPL18, RPL37A, RPL4, RPL10, RPLP1, RPS16, RPS3 | More | | Etidronic-acid | hsa03013 | RNA transport | 5.54E-03 | 15 | P62826, P52298, O14893, P61326, Q9UBU9, Q7Z3B4, P35658, P63279, P68104, Q14152, O75822, P78345, P11940, P20042, Q9Y6A5 | RAN, NCBP2, GEMIN2, MAGOH, NXF1, NUP54, NUP214, UBE2I, EEF1A1, EIF3A, EIF3J, RPP38, PABPC1, EIF2S2, TACC3 | More | | Etidronic-acid | hsa03030 | DNA replication | 3.59E-02 | 2 | P49005, P33993 | POLD2, MCM7 | More | | Etidronic-acid | hsa03040 | Spliceosome | 1.54E-02 | 6 | P17844, Q13435, P51991, P61978, Q15365, P11142 | DDX5, SF3B2, HNRPA3, HNRPK, PCBP1, HSPA8 | More | | Etidronic-acid | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Etidronic-acid | hsa04110 | Cell cycle | 2.34E-02 | 3 | P06493, O60566, P33981 | CDK1, BUB1B, TTK | More | | Etidronic-acid | hsa04115 | p53 signaling pathway | 3.34E-02 | 2 | P31350, P06493 | RRM2, CDK1 | More | | Etidronic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 2.71E-02 | 7 | P18848, Q15436, P11142, Q9NXW2, Q9H3Z4, Q9NR31, P14625 | ATF4, SEC23A, HSPA8, DNAJB12, DNAJC5, SAR1A, HSP90B1 | More | | Etidronic-acid | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Etidronic-acid | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Etidronic-acid | hsa04613 | Neutrophil extracellular trap formation | 7.32E-03 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Etidronic-acid | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | | Etidronic-acid | hsa04714 | Thermogenesis | 4.75E-02 | 6 | Q92618, Q15418, P62753, P13073, Q7KZN9, O15239 | ZNF516, RPS6KA1, RPS6, COX4I1, COX15, NDUFA1 | More | | Etidronic-acid | hsa04920 | Adipocytokine signaling pathway | 4.87E-02 | 2 | Q15831, P20333 | STK11, TNFRSF1B | More | | Etidronic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Etidronic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Etidronic-acid | hsa05010 | Alzheimer disease | 1.31E-02 | 10 | O15239, P13073, Q00535, P01584, P18848, O15169, P67870, P05141, P28070, P43686 | NDUFA1, COX4I1, CDK5, IL1B, ATF4, AXIN1, CSNK2B, SLC25A5, PSMB4, PSMC4 | More | | Etidronic-acid | hsa05020 | Prion disease | 1.09E-02 | 10 | P01584, P46531, P11142, O15239, P13073, P18848, P05141, P28070, P43686, P67870 | IL1B, NOTCH1, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5, PSMB4, PSMC4, CSNK2B | More | | Etidronic-acid | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.24E-03 | 12 | P67870, O15239, P13073, P18848, P05141, P20333, Q00535, O15169, P01584, Q13557, P28070, P43686 | CSNK2B, NDUFA1, COX4I1, ATF4, SLC25A5, TNFRSF1B, CDK5, AXIN1, IL1B, CAMK2D, PSMB4, PSMC4 | More | | Etidronic-acid | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Etidronic-acid | hsa05134 | Legionellosis | 2.00E-02 | 4 | P01584, Q9NR31, P68104, P11142 | IL1B, SAR1A, EEF1A1, HSPA8 | More | | Etidronic-acid | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Etidronic-acid | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Etidronic-acid | hsa05171 | Coronavirus disease - COVID-19 | 6.10E-05 | 15 | P01584, P23396, P62753, P62249, P40429, P62906, P36578, P62917, P32969, P27635, P30050, Q07020, P46776, P61513, P05386 | IL1B, RPS3, RPS6, RPS16, RPL13A, RPL10A, RPL4, RPL8, RPL9, RPL10, RPL12, RPL18, RPL27A, RPL37A, RPLP1 | More | | Etidronic-acid | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | | Etidronic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |